Xencor
Price & Volume
Stats
See more52W Range | $7.13-$22.22 |
Market Cap | $1.6B |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $104.9M |
Revenue Growth (YoY) | 17.5% |
Gross Profit (12 Mos) | -$150.7M |
Diluted EPS | -$2.16 |
News
See moreYahoo Finance • 26 days ago
Xencor advances 17% after revealing ESMO 2026 oral presentation slot
Yahoo Finance • 2 months ago
Incyte lymphoma therapy lifts cancer-free survival by 25% in late-stage trial
Yahoo Finance • 3 months ago
Bi/Multispecific Drugs in Oncology Analytical Tool Featuring Top Developers - Amgen, Hoffmann-La Roche, J&J, Xencor, Biocytogen - Unlocking New Precision, Immune Activation, and Therapeutic Potential
Yahoo Finance • 5 months ago
Stocks Settle Lower as Iran War Boosts Crude Oil and Bond Yields
About
CEO | Dr. Bassil I. Dahiyat Ph.D. |
CFO | Mr. Bart Jan Cornelissen |
Address | 465 North Halstead Street, Pasadena, CA, United States, 91107 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 260 |